3 Stocks Moving The Health Services Industry Upward
All three major indices are trading down today with the
Dow Jones Industrial Average
(
^DJI
) trading down 11 points (-0.1%) at 17,856 as of Thursday, Nov. 5, 2015, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,091 issues advancing vs. 1,846 declining with 161 unchanged.
The Health Services industry currently sits down 0.9% versus the S&P 500, which is down 0.3%. Top gainers within the industry include
(
), up 8.6%,
Fresenius Medical Care AG & Co. KGaA
(
), up 1.6%,
(
), up 1.0%,
(
), up 0.9% and
(
), up 0.5%. On the negative front, top decliners within the industry include
(
), down 24.2%,
(
), down 18.2%,
(
), down 0.9% and
(
), down 0.6%.
TheStreet would like to highlight 3 stocks pushing the industry higher today:
3.
(
) is one of the companies pushing the Health Services industry higher today. As of noon trading, Centene is up $0.83 (1.4%) to $61.60 on light volume. Thus far, 548,929 shares of Centene exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $60.48-$61.80 after having opened the day at $60.83 as compared to the previous trading day's close of $60.77.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Centene Corporation operates as a diversified, multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates in two segments, Managed Care and Specialty Services. Centene has a market cap of $7.3 billion and is part of the health care sector. Shares are up 17.0% year-to-date as of the close of trading on Wednesday. Currently there are 10 analysts who rate Centene a buy, no analysts rate it a sell, and 4 rate it a hold.
TheStreet Ratings rates
Centene
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, increase in net income and notable return on equity. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $1.66 (1.1%) to $158.10 on light volume. Thus far, 207,720 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $156.01-$158.59 after having opened the day at $156.32 as compared to the previous trading day's close of $156.44.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $17.0 billion and is part of the health care sector. Shares are up 22.8% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 3 rate it a hold.
TheStreet Ratings rates
Edwards Lifesciences
as a
. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full
Edwards Lifesciences Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $0.83 (0.7%) to $115.47 on light volume. Thus far, 1.4 million shares of UnitedHealth Group exchanged hands as compared to its average daily volume of 4.5 million shares. The stock has ranged in price between $113.63-$115.61 after having opened the day at $115.01 as compared to the previous trading day's close of $114.64.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. UnitedHealth Group has a market cap of $112.2 billion and is part of the health care sector. Shares are up 13.4% year-to-date as of the close of trading on Wednesday. Currently there are 17 analysts who rate UnitedHealth Group a buy, no analysts rate it a sell, and 2 rate it a hold.
TheStreet Ratings rates
UnitedHealth Group
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full
UnitedHealth Group Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).